Fierce Pharma

DECEMBER 4, 2023

Fujifilm Corporation is spreading the wealth across two production units as the contract development and manufacturing organization (CDMO) juggernaut works through a cell therapy expansion. | Fujifilm is dividing $200 million between a pair of subsidiaries. Those are: Fujifilm Cellular Dynamics, which specializes in development and manufacturing of human induced pluripotent stem cells (iPSC), and the organization’s CDMO for biologics and advanced therapies, Fujifilm Diosynth Biotechnologies.

Specialization 291

Specialization Manufacturing 291

pharmaphorum

DECEMBER 4, 2023

Roche has agreed a deal to acquire US biotech Carmot Therapeutics that if consummated will thrust it into the increasingly competitive market for incretin-based therapies for diabetes and obesity. The Swiss pharma group has agreed to pay $2.7 billion upfront in cash when the deal closes, with shareholders in the US company also in line for up to $400 million if the drug programmes covered by the agreement meet various milestones.

Competition 112

Competition Pharma Marketing 112

Fierce Pharma

DECEMBER 4, 2023

A challenging year for the biotech industry has taken a heavy toll on Chinese manufacturer WuXi Biologics, sending the company’s stock plummeting nearly 24% Monday. | WuXi Biologics expects to miss its original sales target for the year by around $400 million, thanks to reductions across its development and manufacturing services. WuXi blamed the projected miss largely on a COVID-related revenue slowdown and a decline in projects.

Manufacturing 277

Manufacturing Sales 277

MedCity News

DECEMBER 4, 2023

Roche’s Carmot Therapeutics acquisition brings three clinical-stage assets that the companies say could be best-in-class drugs for metabolic disorders. In addition to standalone use, Roche sees the Carmot molecules as part of potential combinations with its own drug candidates.

Biopharma 112

Biopharma Pharma 112

Advertisement

What if you could help your sellers stop wasting 72% of their day on non-selling activities and focus on bringing in revenue? Incorporating AI in your enablement workflows can help you cut down on busy work, get projects done faster, and let your team (and you!) focus on making a bigger impact. We put together this guide to show you how to use AI to cut time and costs for projects, including collateral creation, development of training videos, and automating tedious processes.

Sales Management

Fierce Pharma

DECEMBER 4, 2023

South Africa’s Aspen Pharmacare is growing its global footprint with a new agreement, worth up to 92.6 million euros ($100.3 million), to buy Sandoz’s China operations. | The move is expected to bring in some $95 million in annual sales, the company said. In a separate deal, Sandoz snapped up four Aspen products for $60 million.

Sales 167

Sales 167

MedCity News

DECEMBER 4, 2023

As providers look to find more stability as they pivot into VBC waters, they need to be conscious of the partnerships they forge on this journey. Done correctly, the right collaborative approach can have significant positive downstream impacts for all of a practice’s patients – even the ones not currently in a VBC plan.

Patients 115

Patients 115

European Pharmaceutical Review

DECEMBER 4, 2023

The European Commission (EC ) has authorised ZILBRYSQ ® (zilucoplan)▼ as the first once-daily subcutaneous (SC), targeted peptide inhibitor of complement component 5 (C5) inhibitor for generalised myasthenia gravis ( gMG ). It is also the only C5 inhibitor approved for self-administration by adult patients who are AChR antibody-positive with this disease.

Medicine 105

Medicine Patients Pharmaceutical 105

MedCity News

DECEMBER 4, 2023

Rising out-of-pocket costs and barriers preventing or delaying the utilization of healthcare coverage highlight the need for a comprehensive approach that goes beyond insurance coverage alone and addresses the underlying issues affecting healthcare accessibility and affordability.

Insurance 110

Insurance Healthcare Healthcare 110

European Pharmaceutical Review

DECEMBER 4, 2023

The (bio)pharmaceutical industry is currently facing numerous hurdles in its path to high-efficiency production that are more complex and pressing than ever before. One of the most significant perceived challenges is the ability to implement new innovations and increase productivity while adhering to stringent regulatory demands. The race to develop new drugs and therapies demands rapid drug discovery, testing and time-to-market.

Pharmaceutical manufacturing 105

Pharmaceutical manufacturing Manufacturing Pharmaceutical Pharmaceutical products 105

MedCity News

DECEMBER 4, 2023

A new partnership between Aledade and Anthem Blue Cross and Blue Shield in Virginia aims to improve access to value-based primary care for Medicaid members.

116

116

Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.

The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven

Patients

European Pharmaceutical Review

DECEMBER 4, 2023

A report published by MarketsandMarkets has estimated that the pharmaceutical excipients market will value $14.9 billion by 2028, growing at a CAGR of 6.8 percent between 2023 to 2028. This is compared to the expected revenue for the market in 2023 reaching $10.7 billion. Excipients market opportunities and limitations Major contributing factors regarding growth of the pharmaceutical excipients market are: increasing demand for generic drugs and drug products, increased investment in R&D for

Pharmaceutical 98

Pharmaceutical Marketing Manufacturing Medicine 98

MedCity News

DECEMBER 4, 2023

To create the Golden Age of Healthcare Delivery, we need to understand healthcare workers’ pain points, personalize systems, and make information systems work for them, to ensure that the Golden Age of Medicine is fully realized for all in every community.

Healthcare 108

Healthcare Healthcare Medicine 108

PharmaVoice

DECEMBER 4, 2023

Market expectations for obesity drugs are soaring and competition is heating up. But hitting the heights will require overcoming payer and other issues.

Marketing 98

Marketing Competition 98

MedCity News

DECEMBER 4, 2023

It’s easy to get caught up in the excitement surrounding innovations in the medical field, Amazon Pharmacy Chief Medical Officer Dr. Vin Gupta noted. But when talking about these innovations, healthcare leaders often fail to address questions about whether they will be covered by insurance and whether all patients will be able to benefit from them, he pointed out.

Insurance 107

Insurance Medical Healthcare Healthcare 107

Advertisement

Every marketer knows how important it is to prove their efforts drive sales opportunities, but that’s easier said than done. When problems like sales and marketing misalignment, lack of data, and wasted efforts persist, marketers can’t measure, prove, or increase their impact on revenue at a time when demonstrating marketing value is critical. Using analyst and expert data, this guide to marketing impact and content attribution explains: How B2B buyers use content The most common types of conten

Sales

PharmaVoice

DECEMBER 4, 2023

AstraZeneca’s Gemma Satterthwaite talks to the company’s ambition to transform the entire care experience for patients with blood cancers.

Patients 98

Patients 98

MedCity News

DECEMBER 4, 2023

A new guide from Northeast Business Group on Health helps employers understand the challenges women face when it comes to cardiovascular disease, diabetes and obesity. It also recommends actions that employers can take to support women in their workforce.

101

101

Pharmaceutical Commerce

DECEMBER 4, 2023

Critical factors need to be addressed for pharma stakeholders to realize the full potential of generative artificial intelligence.

Healthcare 102

Healthcare Healthcare Pharma 102

MedCity News

DECEMBER 4, 2023

Eli Lilly’s Jaypirca is now approved for treating three types of blood cancers. While Jaypirca blocks a target already addressed by other cancer therapies, the Lilly molecule does it in a way that sets it apart from the rest of its drug class.

FDA 99

FDA Biopharma Pharma 99

Advertisement

Pharmaceutical Technology

DECEMBER 4, 2023

Eli Lilly has received approval from the US FDA for Jaypirca to treat chronic lymphocytic leukaemia or small lymphocytic lymphoma (CLL/SLL)

FDA 96

FDA 96

MedCity News

DECEMBER 4, 2023

As we embark on the winter season, the significance of respiratory health becomes even more pronounced. The challenges posed by cold weather, compounded by air pollution, necessitate a proactive approach.

96

96

Pharmaceutical Technology

DECEMBER 4, 2023

Roche has signed an agreement for the acquisition of US-based company Carmot Therapeutics in a deal valued at $2.7bn, to be paid in cash.

98

98

PharmaTimes

DECEMBER 4, 2023

In England, an estimated 4,500 people are living with undiagnosed HIV - News - PharmaTimes

114

114

Advertisement

Quotas need to be hit. Revenue goals need to be met. This reality makes shortening sales onboarding time a top priority. Organizations with a standard onboarding process boost employee retention by 58% and increase productivity by 50%. Unfortunately, many companies struggle with inefficient processes that lead to high turnover and missed revenue opportunities.

Sales

Pharmaceutical Technology

DECEMBER 4, 2023

The US Food and Drug Administration (FDA) has granted approval for Ambio’s generic version of Forteo for the treatment of osteoporosis.

Food and Drug Administration 98

Food and Drug Administration FDA Food 98

pharmaphorum

DECEMBER 4, 2023

Undiagnosed dementia in UK needs drastic action, says review Phil.

112

112

Pharmaceutical Technology

DECEMBER 4, 2023

The agreement allows Guardant Health to leverage Cancer Research UK’s network to validate its technologies.

Networking 97

Networking 97

PharmaTimes

DECEMBER 4, 2023

The neurological condition affects around 50 million people worldwide - News - PharmaTimes

97

97

Advertisement

Distribution

pharmaphorum

DECEMBER 4, 2023

AstraZeneca links with Absci on AI for biologics discovery Phil.

103

103

Pharmaceutical Technology

DECEMBER 4, 2023

The $247m deal will focus on the use of generative artificial intelligence to develop an antibody therapy for an unnamed cancer.

64

64

pharmaphorum

DECEMBER 4, 2023

UK primary care group adopts digital heart failure pathway Phil.

100

100

Contrarian Sales Techniques

DECEMBER 4, 2023

In the bustling world of pharmaceutical sales, the role of a sample bag is often understated yet crucial. Imagine this: a pharmaceutical sales representative, armed with the latest and greatest in medical advancements, sets out to make their mark in the competitive healthcare industry. The sample bag they carry isn’t just a container. It’s a mobile showcase, a silent yet persuasive partner in every pitch and presentation.

Sales 52

Sales Pharmaceutical Sales Pharma Transportation 52

Advertisement

Are your sellers unsure about using AI in their day-to-day workflows? Or are they eager to try but uncertain where to start? They might be asking: Which tasks are best suited for AI? How will using AI affect my relationship with my customers? With so many tools available, which ones are the most useful to me? To help answer these and other common questions about using AI during the sales cycle, we surveyed B2B sellers who were early adopters to get their insight and advice about how to use gen A

Sales